Gene Activity List


Gene Activity List

Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type IX, alpha CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage gated, type VIII, alpha CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type VII, alpha CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type IV, beta CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type IV, alpha CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type III, alpha CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type II, beta CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type II, alpha 2 CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type I, beta CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type I, alpha CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type IV, beta DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel associated protein 1 DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel associated protein 2 DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type III, beta DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type I, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type IX, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type VII, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
amiloride-sensitive cation channel 5, intestinal DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type III, beta DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type XI, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type I, beta DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type 10, alpha polypeptide DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type IV, alpha polypeptide DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type V, alpha polypeptide DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type II, beta DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, nonvoltage-gated 1 alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, nonvoltage-gated 1 gamma DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, nonvoltage-gated 1 beta DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type XI, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, nonvoltage-gated 1, gamma DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, nonvoltage-gated 1, delta DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, nonvoltage-gated 1 alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type X, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type IX, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage gated, type VIII, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type VII, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type IV, beta DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type IV, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
phosphodiesterase 4C, cAMP-specific GENISTEIN Phosphodiesterase PDE4 74% 10.924uM NoneNone View
sodium channel, voltage-gated, type III, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type II, beta DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type II, alpha 2 DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type I, beta DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type I, alpha DOMPERIDONE Sodium Channel, Site 2 100% 1.035uM .944uM View
sodium channel, voltage-gated, type XI, alpha FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, nonvoltage-gated 1, gamma FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, nonvoltage-gated 1, delta FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, nonvoltage-gated 1 alpha FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type X, alpha FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type IX, alpha FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage gated, type VIII, alpha FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type VII, alpha FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type IV, beta FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type IV, alpha FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type III, alpha FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type II, beta FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type II, alpha 2 FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type I, beta FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type I, alpha FLUNARIZINE Sodium Channel, Site 2 100% .263uM .24uM View
sodium channel, voltage-gated, type IV, beta TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel associated protein 1 TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel associated protein 2 TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type III, beta TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type I, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type IX, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type VII, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
amiloride-sensitive cation channel 5, intestinal TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type III, beta TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type XI, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type I, beta TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type 10, alpha polypeptide TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type IV, alpha polypeptide TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type V, alpha polypeptide TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type II, beta TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, nonvoltage-gated 1 alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, nonvoltage-gated 1 gamma TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, nonvoltage-gated 1 beta TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type XI, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, nonvoltage-gated 1, gamma TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, nonvoltage-gated 1, delta TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, nonvoltage-gated 1 alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type X, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type IX, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage gated, type VIII, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type VII, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type IV, beta TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type IV, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type III, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type II, beta TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type II, alpha 2 TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type I, beta TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type I, alpha TERFENADINE Sodium Channel, Site 2 100% .078uM .071uM View
sodium channel, voltage-gated, type IV, beta CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel associated protein 1 CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel associated protein 2 CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
sodium channel, voltage-gated, type III, beta CINNARIZINE Sodium Channel, Site 2 100% .414uM .377uM View
estrogen receptor 1 GENISTEIN Estrogen ERbeta 105% .00288uM .000594uM View
estrogen receptor 1 GENISTEIN Estrogen ERbeta 105% .00288uM .000594uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 TOPOTECAN CYP450-3A4 Inhibition 100% 1.5211uM NoneNone View
potassium voltage-gated channel, subfamily H, member 8 EBASTINE Potassium Channel HERG 100% .1048uM .0858uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 EBASTINE Potassium Channel HERG 100% .1048uM .0858uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 EBASTINE Potassium Channel HERG 100% .1048uM .0858uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 EBASTINE Potassium Channel HERG 100% .1048uM .0858uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 EBASTINE Potassium Channel HERG 100% .1048uM .0858uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 EBASTINE Potassium Channel HERG 100% .1048uM .0858uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 EBASTINE Potassium Channel HERG 100% .1048uM .0858uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 EBASTINE Potassium Channel HERG 100% .1048uM .0858uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 EBASTINE Potassium Channel HERG 100% .1048uM .0858uM View
sodium channel, voltage-gated, type I, beta PERHEXILINE Sodium Channel, Site 2 100% .5106uM .4658uM View
sodium channel, voltage-gated, type I, alpha PERHEXILINE Sodium Channel, Site 2 100% .5106uM .4658uM View
sodium channel, voltage-gated, type IV, beta SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel associated protein 1 SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel associated protein 2 SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type III, beta SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type I, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type IX, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type VII, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
amiloride-sensitive cation channel 5, intestinal SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type III, beta SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
phosphodiesterase 4D GENISTEIN Phosphodiesterase PDE4 74% 10.924uM NoneNone View
sodium channel, voltage-gated, type XI, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type I, beta SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type 10, alpha polypeptide SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type IV, alpha polypeptide SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type V, alpha polypeptide SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type II, beta SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, nonvoltage-gated 1 alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, nonvoltage-gated 1 gamma SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, nonvoltage-gated 1 beta SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type XI, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, nonvoltage-gated 1, gamma SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, nonvoltage-gated 1, delta SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, nonvoltage-gated 1 alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type X, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type IX, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage gated, type VIII, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type VII, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type IV, beta SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type IV, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type III, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type II, beta SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type II, alpha 2 SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type I, beta SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
sodium channel, voltage-gated, type I, alpha SULOCTIDIL Sodium Channel, Site 2 100% .1749uM .1596uM View
tachykinin receptor 2 HEXACHLOROPHENE Tachykinin NK2 100% 4.1392uM 1.3797uM View
histamine receptor H 2 SULOCTIDIL Histamine H2 100% .1081uM .0885uM View
epidermal growth factor receptor TRANS-PLATINUM(II)DIAMMINE DICHLORIDE Protein Tyrosine Kinase, EGF Receptor 100% 1.0633uM NoneNone View
Protein-tyrosine kinase, Fyn TRANS-PLATINUM(II)DIAMMINE DICHLORIDE Protein Tyrosine Kinase, Fyn 100% .5645uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B BW-723C86 Serotonin 5-HT2B 100% .0811uM .0516uM View
potassium voltage-gated channel, subfamily H, member 8 AMIODARONE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 6 AMIODARONE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 7 AMIODARONE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 2 AMIODARONE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 5 AMIODARONE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 3 AMIODARONE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 4 AMIODARONE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 1 AMIODARONE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 1 AMIODARONE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H, member 8 TERFENADINE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 6 TERFENADINE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 7 TERFENADINE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 2 TERFENADINE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 5 TERFENADINE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 3 TERFENADINE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 4 TERFENADINE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 1 TERFENADINE Potassium Channel HERG 100% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 1 TERFENADINE Potassium Channel HERG 100% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, gamma subunit 7 SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, gamma subunit 6 SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, gamma subunit 5 SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, gamma subunit 4 SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, gamma subunit 3 SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, gamma subunit 2 SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, gamma subunit 1 SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, beta 4 subunit SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, beta 3 subunit SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, beta 2 subunit SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, alpha 1F subunit SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, beta 1 subunit SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit SULOCTIDIL Calcium Channel Type L, Dihydropyridine 100% .2595uM .1668uM View